Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Polysubstance Drug Use (Indiscriminate Drug Use) clinical trials
1 of 2 indexed Polysubstance Drug Use (Indiscriminate Drug Use) trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Polysubstance Drug Use (Indiscriminate Drug Use): 2 US clinical trials tracked, 1 recruiting.
Polysubstance Drug Use (Indiscriminate Drug Use) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Chestnut Health Systems, running 1 of these trials.
Enrollment posture brief
Registry condition polysubstance-drug-use-indiscriminate-drug-use
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Polysubstance Drug Use (Indiscriminate Drug Use) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Polysubstance Drug Use (Indiscriminate Drug Use) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Polysubstance Drug Use (Indiscriminate Drug Use) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Polysubstance Drug Use (Indiscriminate Drug Use) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Polysubstance Drug Use (Indiscriminate Drug Use) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Polysubstance Drug Use (Indiscriminate Drug Use) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Polysubstance Drug Use (Indiscriminate Drug Use) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Chestnut Health Systems sponsors the most Polysubstance Drug Use (Indiscriminate Drug Use) trials on record, review their full trial history before evaluating a specific study. See Chestnut Health Systems's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polysubstance Drug Use (Indiscriminate Drug Use) condition card totals 2 registered trials; most-linked intervention Patient Navigation and mHealth (PN+mHealth); top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.